Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LB-1908 by Legend Biotech for Gastric Cancer: Likelihood of Approval
LB-1908 is under clinical development by Legend Biotech and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
LB-1908 by Legend Biotech for Esophageal Cancer: Likelihood of Approval
LB-1908 is under clinical development by Legend Biotech and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase...
LB-1908 by Legend Biotech for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
LB-1908 is under clinical development by Legend Biotech and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According...
LB-1908 by Legend Biotech for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
LB-1908 is under clinical development by Legend Biotech and currently in Phase I for Metastatic Adenocarcinoma of The Pancreas. According...